$7.9 M

VBIO Mkt cap, 16-Oct-2020
Vitality Biopharma Net income (Q1, 2021)-740.2 K
Vitality Biopharma EBIT (Q1, 2021)-740.7 K
Vitality Biopharma Cash, 30-Jun-20201.8 M
Vitality Biopharma EV6.4 M

Vitality Biopharma Income Statement

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

248.3k163.4k102.4k258.3k

Revenue growth, %

(34%)(37%)

Cost of goods sold

149.5k108.3k77.9k

Gross profit

98.9k55.1k24.5k

Gross profit Margin, %

40%34%24%

R&D expense

613.1k894.0k1.9m1.8m1.0m

General and administrative expense

2.2m2.6m2.5m3.7m2.7m

Operating expense total

2.8m3.5m4.4m13.0m3.7m

EBIT

(2.7m)(3.5m)(4.4m)(13.2m)(3.7m)

EBIT margin, %

(1104%)(2125%)(4293%)(5123%)

Interest expense

363.01.0k110.6k

Interest income

1.2k

Pre tax profit

(3.6m)

Net Income

(141.3k)(5.2m)(4.3m)(13.1m)(4.4m)

Vitality Biopharma Balance Sheet

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018Q3, 2018Q2, 2019Q3, 2019Q2, 2020Q3, 2020Q1, 2021

Cash

394.054.5k16.6k892.1k596.0k1.2m551.3k1.8m830.1k1.8m1.1m1.2m692.7k208.1k20.5k33.7k153.8k815.5k1.4m336.7k7.5m4.0m3.1m1.8m

Accounts Receivable

27.9k39.4k39.7k43.3k42.9k76.8k39.2k27.9k32.2k20.2k13.5k20.1k45.9k

Prepaid Expenses

612.03.6k3.2k229.5k26.2k8.8k10.5k9.3k9.5k21.5k9.5k2.5k2.5k2.5k3.1k3.1k3.1k8.1k21.3k19.1k13.2k13.2k

Inventories

15.9k19.4k34.8k8.5k9.4k7.9k6.5k6.5k6.5k

Current Assets

1.0k58.1k19.8k1.1m749.6k1.3m637.2k1.9m7.5m4.0m3.1m1.8m

PP&E

12.3k

Goodwill

9.1m

Total Assets

1.0k58.1k19.8k1.1m791.3k1.3m637.2k1.9m883.4k1.9m1.1m1.3m747.5k295.2k69.2k71.1k195.6k838.8k1.4m364.8k16.6m4.2m3.3m1.9m

Accounts Payable

6.4k38.7k32.8k54.3k83.7k182.5k111.2k166.5k161.3k203.5k137.3k159.8k183.5k161.4k233.0k307.1k374.6k280.1k197.5k314.7k387.7k1.2m977.0k756.5k

Short-term debt

81.8k181.8k196.8k250.0k129.3k

Current Liabilities

95.2k236.7k242.1k63.9k382.4k1.7m1.5m1.1m1.6m1.4m1.2m

Long-term debt

625.0k762.5k625.0k68.7k34.6k151.4k

Total Debt

81.8k181.8k196.8k625.0k762.5k625.0k250.0k68.7k34.6k280.7k

Total Liabilities

781.2k1.2m2.2m2.1m1.6m1.5m1.5m1.6m2.1m978.9k379.1k582.6k991.6k876.7k581.5k399.3k787.9k745.9k1.6m1.4m1.2m

Common Stock

7.4k51.5k51.5k52.4k53.9k59.8k59.9k65.6k67.2k72.4k72.9k78.3k78.6k79.1k10.6k12.9k15.9k23.0k24.0k24.5k36.3k50.6k50.6k50.6k

Additional Paid-in Capital

17.7k(26.4k)(26.4k)2.1m2.9m4.2m4.5m7.3m8.5m11.0m11.0m11.2m11.3m11.6m12.3m13.2m15.9m20.0m21.9m24.0m41.4m47.5m47.6m47.9m

Retained Earnings

1.9m3.2m5.1m5.9m6.9m(9.0m)(10.4m)(11.5m)(12.2m)(11.7m)(11.7m)(13.0m)(14.1m)(16.6m)(19.7m)(21.0m)(24.4m)(25.6m)(45.0m)(45.8m)(47.3m)

Total Equity

(94.2k)(178.6k)(222.3k)366.9k(379.6k)(949.8k)(1.5m)254.4k(591.4k)319.1k(491.4k)(895.8k)(231.4k)(83.9k)(513.3k)(920.5k)(681.2k)257.3k982.5k(423.1k)15.9m2.6m1.9m667.1k

Debt to Equity Ratio

-0.5 x

Debt to Assets Ratio

1.2 x

Financial Leverage

0 x-0.3 x-0.1 x3.1 x-2.1 x-1.3 x-0.4 x7.4 x-1.5 x5.8 x-2.3 x-1.4 x-3.2 x-3.5 x-0.1 x-0.1 x-0.3 x3.3 x1.4 x-0.9 x1 x1.6 x1.7 x2.9 x

Vitality Biopharma Cash Flow

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(1.3m)(2.7m)(4.2m)(4.0m)(141.3k)(5.2m)(4.3m)(13.1m)(4.4m)

Depreciation and Amortization

12.3k

Accounts Receivable

(22.1k)31.2k11.2k5.4k4.6k

Inventories

(8.5k)2.0k6.5k

Accounts Payable

71.6k32.5k107.7k4.1k110.9k158.1k(173.2k)285.9k221.6k

Cash From Operating Activities

(208.7k)(1.6m)(2.1m)(2.5m)(1.7m)(1.4m)(2.9m)(3.7m)(3.6m)

Capital Expenditures

38.1k

Cash From Investing Activities

(39.6k)(1.0k)10.5k141.5k

Cash From Financing Activities

769.9k1.5m3.1m1.5m1.4m2.4m2.4m8.9m

Net Change in Cash

521.6k(139.7k)1.0m(1.0m)(294.3k)1.1m(496.5k)5.3m(3.6m)

Interest Paid

Income Taxes Paid

Free Cash Flow

(246.8k)

Vitality Biopharma Ratios

USDQ1, 2012